Strategy projects

• Portfolio / franchise assessment
  • Developed worldwide 10-year strategic plans for the Diabetes and CNS franchises of a Top 10 R&D-based pharma company
  • Elaborated portfolio strategies for both global players and mid-size European companies
• New launches / growth strategies
  • Structured worldwide launch plan of a major new chemical entity
  • Developed market access strategy for an orphan drug across Europe
  • Assessed attractiveness of the North-African market for a biotech product 
  • Elaborated growth strategy for a major respiratory compound in France
  • Screened and assessed product candidates to support the external growth of a mid size company in France 
  • Elaborated entry strategies for generics companies in hospital and OTC markets
  • Evaluated sales potential for a new biotherapy
  • Evaluated financial needs and development opportunities for vaccines in middle income and developing countries
• Lifecycle optimization
  • Innovative drugs: Developed strategy for a highly-specialized hospital compound in Europe
  • Me-too's: Created strategy for a major gastroenterology drug in France
  • Off-patent drugs:
    • Developed strategies for more than 12 compounds across several therapeutic areas (cardiology, diabetes, CNS, gynaecology, pulmonology, gastroenterology…)
    • Evaluated the impact of a biosimilar launch in oncology
• Resource allocation optimization
  • Created and implemented worldwide resource allocation system for a specialized global company
  • Evaluated brand sensitivity to promotional investment for numerous primary care and hospital products
• Operating strategies
  • Elaborated differentiating communication strategy towards hospital stakeholders allowing client to preserve leading position
  • Evaluated opportunity to build and leverage competitive advantage with a patient database for a hospital compound
  • Evaluated a commercial strategy targeted at Italian pharmacists
  • Optimized hospital supply chain for a leading biotech company
  • Identified win-win partnership opportunities with open care pharmacists to leverage their role in increasing sales 
• Due diligences
  • Evaluated the competitive position and growth potential of various companies in the areas of drug manufacturing, distribution and commercialization (OTC products, mature compounds, generics)